John Hodgman

John Hodgman discloses dealings in 3 companies, chiefly Intermune Inc, Immersion Corp and Sarepta Therapeutics, Inc. The record holds 60 filings, for trades running from 15 May 2007 to 27 February 2015.

Every open-market trade on record is a sale: 15 sales worth €9.2M. Outside the open market, there are 31 share grants and 11 option exercises.

Most recently, on 3 March 2015, the filings show a share grant in Sarepta Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.